Zion Market Research has published a new report titled “Nephrostomy Devices Market by Product (guidewires, drainage tubes, nephrostomy catheters, sheath dilators and others) and End user (Hospitals, Emergency Clinics, Ambulatory Surgical Centers (ASCs) and others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025”.
According to the report, global demand for Nephrostomy Devices Market was valued at approximately USD 932.89 Million in 2018, and is expected to generate revenue of around USD 1,511.98 Million by end of 2025, growing at a CAGR of around 7.26 % between 2018 and 2025.
Nephrostomy is an opening between the kidney and the skin. A tube of nephrostomy is a thin plastic tube which passes through the leg, through the body, and then through the kidney to the point where the urine collects. The function is to temporarily clear the blocked urine. This helps the kidney to function properly, and protects it from further damage. It also helps in making any infection clear. Ultrasound and/or X-ray pictures (or images) direct the operation. Contrast is injected into the part of the kidney which collects urine. This helps to place the tube which drains the kidney in the best position in the collection system. Nephrostomy catheter placement is usually done under image supervision by interventional radiologists in the radiology room or in the operating room. The most common cause of nephrostomy is cancers of reproductive organs such as ovarian cancer, colon cancer, etc. Dilation catheters are the newest solution to the problems of percutaneous dilation.
Request Free Sample is Available @ https://www.zionmarketresearch.com/sample/nephrostomy-devices-market
As well, increasing popularity drives the market for minimally invasive procedures. Increasing cases of lifestyle related disorder are also likely to contribute to the industry’s growth. Developing health-care infrastructure in emerging economies is already affecting the global market. Nephrostomy catheters are widely used to clear an apparatus that collects blocked urine. This blockage leads to hydronephrosis, which is achieved with the help of nephrostomy catheters. As a result, the increase in hydronephrosis is expected to raise demand for catheters, accelerating market growth in nephrostomy devices. Increasing cases of lung, ovarian, and prostate cancer are also expected to have a positive effect on consumer demand over the forecast years. Another key driver is the growing occurrence of post-surgical infections in patients with kidney transplants.
The market for Nephrostomy Devices is segmented based on product, end user, and region. Based on Product, the market is segmented into guidewires, drainage tubes, nephrostomy catheters, sheath dilators and others. The Guidewires category is expected to hold the highest market share in the forecast period due to the less intrusive nature of the product. -Elderly people and the prevalence of urinary and bladder disorders are expected to increase consumer demand, thereby impacting growth in the segment. Guidewire manufacturers are focused on partnering with health care providers to increase their customer base and strengthen their market role. Therefore, the efforts of these manufacturers and the advent of well-established and skilled practitioners in the developed economies are expected to increase demand for guidewires. It is expected that technological advances in nephrostomy devices, such as the launch of balloon dilation catheter with original multilayer technology, will provide lucrative opportunities for the industry.
Based on the End user segment, the market is segmented into Hospitals, Emergency Clinics, Ambulatory Surgical Centers (ASCs) and others. Ambulatory surgical centers (ASCs) are expected to witness the fastest CAGR from 2019 to 2026, as they provide more customized services. Moreover, better results in relation to hospitals and other healthcare facilities also raise the group. The risk of infection during surgery in ASCs is half that of hospitals, which also helps boost the segment’s growth. In turn, ASCs ensure patients receive personalized care and increased patient experience, as they are not required to treat different types of diseases and disorders.
Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. Because of the favorable reimbursement policies, increased drug recognition, the availability of highly skilled doctors and the presence of well-established health care facilities in the area, substantial growth is expected in the future as well. It is also expected that the rapid adoption of technologically advanced medicinal products will drive the market for the region. Increasing government support for R&D activities in surgical instruments and procedures also has a positive impact on regional market development. Asia Pacific is expected to grow at the highest CAGR from 2019 to 2025, due to increasing cases of kidney disorders, supporting government initiatives and multiple opioid awareness-raising NGO programs. Furthermore, the presence of a large number of key companies in China and India contributes to industry growth. However, the rapidly expanding medical tourism market in the developing economies of Asia Pacific is expected to increase the demand for the product, thus increasing market growth.
Some of the players included in Nephrostomy Devices market are Boston Scientific Corp., Teleflex, Inc., Cardinal Health, Becton, Dickinson and Company, Cook Medical, B. Braun Melsungen AG, Coloplast Group, Olympus Corp., Argon Medical and Uresil LLC amongst others.
The report segments global Nephrostomy Devices market as follows:
Global Nephrostomy Devices Market: Product Segment Analysis
Global Nephrostomy Devices Market: End user Segment Analysis
Global Nephrostomy Devices Market: Regional Segment Analysis
To view TOC of this report is available upon request @ https://www.zionmarketresearch.com/toc/nephrostomy-devices-market